Literature DB >> 25231860

Disease models: Statins give bone growth a boost.

Bjorn R Olsen1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25231860     DOI： 10.1038/nature13750

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

1.  A more efficient method to generate integration-free human iPS cells.

Authors:  Keisuke Okita; Yasuko Matsumura; Yoshiko Sato; Aki Okada; Asuka Morizane; Satoshi Okamoto; Hyenjong Hong; Masato Nakagawa; Koji Tanabe; Ken-ichi Tezuka; Toshiyuki Shibata; Takahiro Kunisada; Masayo Takahashi; Jun Takahashi; Hiroh Saji; Shinya Yamanaka
Journal:  Nat Methods       Date:  2011-04-03       Impact factor: 28.547

2.  Standard weight for height curves in achondroplasia.

Authors:  A G Hunter; J T Hecht; C I Scott
Journal:  Am J Med Genet       Date:  1996-03-29

3.  Use of statins for dyslipidemia in the pediatric population.

Authors:  Lea S Eiland; Paige K Luttrell
Journal:  J Pediatr Pharmacol Ther       Date:  2010-07

4.  Human induced pluripotent stem cells differentiated into chondrogenic lineage via generation of mesenchymal progenitor cells.

Authors:  Noriaki Koyama; Masako Miura; Kazumasa Nakao; Eri Kondo; Toshihito Fujii; Daisuke Taura; Naotetsu Kanamoto; Masakatsu Sone; Akihiro Yasoda; Hiroshi Arai; Kazuhisa Bessho; Kazuwa Nakao
Journal:  Stem Cells Dev       Date:  2012-09-04       Impact factor: 3.272

5.  Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.

Authors:  Akihiro Yamashita; Miho Morioka; Hiromi Kishi; Takeshi Kimura; Yasuhito Yahara; Minoru Okada; Kaori Fujita; Hideaki Sawai; Shiro Ikegawa; Noriyuki Tsumaki
Journal:  Nature       Date:  2014-09-17       Impact factor: 49.962

Review 6.  Achondroplasia: pathogenesis and implications for future treatment.

Authors:  Melanie B Laederich; William A Horton
Journal:  Curr Opin Pediatr       Date:  2010-08       Impact factor: 2.856

7.  Mortality in achondroplasia study: a 42-year follow-up.

Authors:  Julia Wynn; Terri M King; Michael J Gambello; D Kim Waller; Jacqueline T Hecht
Journal:  Am J Med Genet A       Date:  2007-11-01       Impact factor: 2.802

8.  Protective effect of atorvastatin in cultured osteoarthritic chondrocytes.

Authors:  Theodora Simopoulou; Konstantinos N Malizos; Lazaros Poultsides; Aspasia Tsezou
Journal:  J Orthop Res       Date:  2010-01       Impact factor: 3.494

9.  Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.

Authors:  Akihiro Yasoda; Yasato Komatsu; Hideki Chusho; Takashi Miyazawa; Ami Ozasa; Masako Miura; Tatsuya Kurihara; Tomohiro Rogi; Shoji Tanaka; Michio Suda; Naohisa Tamura; Yoshihiro Ogawa; Kazuwa Nakao
Journal:  Nat Med       Date:  2003-12-14       Impact factor: 53.440

10.  Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.

Authors:  Florence Lorget; Nabil Kaci; Jeff Peng; Catherine Benoist-Lasselin; Emilie Mugniery; Todd Oppeneer; Dan J Wendt; Sean M Bell; Sherry Bullens; Stuart Bunting; Laurie S Tsuruda; Charles A O'Neill; Federico Di Rocco; Arnold Munnich; Laurence Legeai-Mallet
Journal:  Am J Hum Genet       Date:  2012-11-29       Impact factor: 11.025
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.